MINNEAPOLIS (CN) - More than 90 percent of patients diagnosed with nephrogenic systemic fibrosis, a progressive, incurable and potentially deadly disease, received injections of General Electric's "Omniscan" MRI contrast dye, William Clark claims in Federal Court.
Clark claims he got the disease from intravenously injected Omniscam, which contains the toxic metal gadolinium. Omniscan is particularly dangerous to patients with renal insufficiency and GE knew it and failed to warn, Clark claims. The disease causes discoloration, swelling and thickening of the skin, muscular weakness, inhibits joint flexion and often progresses to "painful inability to use the arms, legs, hands, feet and other joints," the suit states. It can progress to "a fibrotic or scarring condition of other body organs such as the lungs, hear, liver and musculature, which inhibits the ability of these organs to function properly and may lead to death," Clark says. His lead attorney is Robinson, Calcagnie, Robinson of Newport Beach, Calif.
Categories / Uncategorized
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.